Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer

Dr. Linh Alejandro, a clinical oncology pharmacist at the University of California, San Diego Health Systems discusses the approval of olaparib for germline BRCA-mutated metastatic breast cancer.

Episode metadata supplied by the publisher feed · Published May 30, 2018

Embed this episode

Attribution link and audio player

NOW PLAYING

Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer

0:00 5:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ASCO Education?

This episode is 5 minutes long.

When was this ASCO Education episode published?

This episode was published on May 30, 2018.

Can I download this ASCO Education episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!